Episode
Betting On The Unconventional With Draper Associates’ Andy Tang
- Podcast
- FYI - For Your Innovation
- Published
- Jun 18, 2026
- Duration seconds
- 36034
- Processing state
not_requested- Canonical source
- https://podcast.show/fyi_podcast/episode/154031118/
Actions
POST https://stenobird.com/v1/public/podcasts/fyi-for-your-innovation-857719/episodes/betting-on-the-unconventional-with-draper-associates-andy-tang/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/fyi-for-your-innovation-857719/betting-on-the-unconventional-with-draper-associates-andy-tang.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of FYI, Brett Winton and Chase Prather host Andy Tang, partner at Draper Associates, to discuss how venture capital is evolving alongside AI, deep tech, and shifting market dynamics. Andy reflects on his 20-year investing career, the growing importance of AI-native companies, and why the cost of execution is rapidly declining for startups. The conversation explores founder psychology, the role of contrarian investing, and how Draper approaches unconventional ideas ranging from artificial wombs to AI-generated companies and personalized cancer therapies. Andy also shares insights on venture ecosystems, market cycles, and the characteristics that separate enduring founders from everyone else. Key Points From This Episode: 00:00:00 Introduction 00:06:09 How AI-native startups are reshaping venture capital strategies. 00:20:47 Why the cost of building companies is falling dramatically. 00:28:18 How venture ecosystems evolve through successful Initial Public Offering (IPO) cycles. 00:42:11 How venture investors evaluate founder ambition and long-term outcomes. 00:50:02 How AI could enable single-person or founderless companies. 00:53:26 The idea of growing replacement organs outside the human body. 00:54:01 Personalized “end-of-one” cancer treatments and custom clinical trials. 00:57:05 Why declining biotech costs could transform healthcare economics. Editing and post-production work for this episode was provided by The Podcast Consultant ( https://thepodcastconsultant.com )